Motor fatigue and fatigability in early multiple sclerosis patients: an analysis of clinical, radiological and psychological underpinnings

早期多发性硬化症患者的运动疲劳和易疲劳性:临床、放射学和心理学基础分析

阅读:2

Abstract

BACKGROUND: While fatigue is highly reported in newly diagnosed people with Multiple Sclerosis (pwMS) and motor fatigability is reported in about 20% of non-disabled patients, relationship among them in early MS has been less studied. OBJECTIVE: To evaluate correlations between fatigue and motor fatigability in early pwMS, and their clinical, radiological, psychological underpinnings. METHODS: Relapsing pwMS aged 18-65 years, Expanded Disability Status Scale (EDSS) score <2.0, disease duration <5 years were recruited. PwMS underwent clinical, cognitive, radiological assessment. They performed a 6-minute-walking-test; fatigability was calculated as the ratio of distance walked in the final minute to the first minute (distance walking index, DWI6−1). Fatigue was evaluated through the Modified Fatigue Impact Scale (MFIS). Spearman ρ examined the relationship among variables; linear regression analyses examined predictors of fatigue and fatigability. RESULTS: 70 pwMS (age 37.8+11years; female n=50, 71.4%, EDSS 1.5[1;2]) were enrolled. 15 (21.4%) reported significant levels of fatigue, 14 (20%) presented motor fatigability. Fatigue and motor fatigability were not significantly correlated with one another (ρ=0.100;p=0.425) or with other clinical, cognitive, radiological features. Fatigue was related to Hospital Anxiety and Depression Scale (HADS) anxiety subscale (ρ=0.375,p=0.002), Beck Depression Inventory (BDI-II) (ρ=0.543;p<0.001), neuroticism (ρ=0.313;p=0.006), and all subscales of MS-Quality-Of-Life 54. We did not find predictors of fatigability, while HADS-anxiety (b=0.76; p=0.003) and BDI-II (b=0.33; p=0.009) significantly predicted fatigue. CONCLUSIONS: Our results support different neurobiological underpinnings for motor fatigue and fatigability and reinforce the need for a multidimensional assessment from the earliest stages of the disease, to tailor therapeutic and rehabilitation strategies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。